Who Paid My Doc
Genevieve Otto
Dentist, Orthodontics and Dentofacial Orthopedics Chesterfield, MO Doctor of Dentistry
NPI 1851683510 CMS profile 416211
#6 McBride And Son Corporate Center Drive, Suite 200, Chesterfield, MO 63005
General payments
$5,245
Research payments
$0
Ownership & investment interest
$0
Through program year 2025, Genevieve Otto of Chesterfield, MO is reported in the CMS Open Payments database as having received $5,245 across 40 general payments and $0 in research payments paid to them.
No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.
General payments for this record sit in the 93rd percentile of Dentist, Orthodontics and Dentofacial Orthopedics profiles with reported payments. Percentile describes the distribution, not the conduct.
By program year
7 rows| Year | Kind | Relative to this record's peak year | Amount | Records |
|---|---|---|---|---|
| 2025 | General | $3,553 | 12 | |
| 2024 | General | $98 | 4 | |
| 2023 | General | $102 | 7 | |
| 2022 | General | $69 | 4 | |
| 2021 | General | $103 | 4 | |
| 2020 | General | $1,259 | 7 | |
| 2019 | General | $61 | 2 |
Beside peers
- Genevieve Otto
- Dentist, Orthodontics and Dentofacial Orthopedics median
- Middle half of Dentist, Orthodontics and Dentofacial Orthopedics
- National median
In program year 2025, general payments to Genevieve Otto were reported at $3,553. Among 7,792 Dentist, Orthodontics and Dentofacial Orthopedics profiles paid that year, the median was $146 and the middle half received between $52 and $382.
Show as a table
| Year | Genevieve Otto | Dentist, Orthodontics and Dentofacial Orthopedics median | Middle half | National median |
|---|---|---|---|---|
| 2019 | $61 | $100 | $36–$271 | $163 |
| 2020 | $1,259 | $111 | $63–$221 | $114 |
| 2021 | $103 | $110 | $46–$231 | $132 |
| 2022 | $69 | $122 | $44–$312 | $149 |
| 2023 | $102 | $145 | $51–$392 | $160 |
| 2024 | $98 | $126 | $50–$309 | $164 |
| 2025 | $3,553 | $146 | $52–$382 | $169 |
Breakdown
A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.
Records
40 reportedEvery payment, record by record
Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.
Other Dentist, Orthodontics and Dentofacial Orthopedics in Missouri
Mazyar Moshiri
Dentist, Orthodontics and Dentofacial Orthopedics · Saint Louis, MO
Brent Bankhead
Dentist, Orthodontics and Dentofacial Orthopedics · O Fallon, MO
Andrew Hayes
Dentist, Orthodontics and Dentofacial Orthopedics · Chesterfield, MO
Zachary Varble
Dentist, Orthodontics and Dentofacial Orthopedics · Saint Charles, MO
Rebecca Schreiner
Dentist, Orthodontics and Dentofacial Orthopedics · Chesterfield, MO
Kevin Kaiser
Dentist, Orthodontics and Dentofacial Orthopedics · Saint Louis, MO
Related records
Dentist, Orthodontics and Dentofacial Orthopedics in Missouri
Practitioners in the same specialty and state, ranked by reported value.
All Dentist, Orthodontics and Dentofacial Orthopedics
Everyone recorded under this specialty, nationwide.
Doctors in Missouri
Every practitioner in the state with a reported payment.
How to read this page
What each amount means, and what it does not mean.
What this means
U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.
An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.
Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.